Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 10Phase 1 3Phase 1/2 2Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 27Lymphoma 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma, Non-Hodgkin 21Leukemia 21Multiple Myeloma 18Leukemia, Myeloid, Acute 18Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 16Myelodysplastic Syndromes 15Lymphoma, Mantle-Cell 15Lymphoma, Follicular 15Leukemia, Lymphocytic, Chronic, B-Cell 14Congenital Abnormalities 12Lymphoma, B-Cell, Marginal Zone 11Burkitt Lymphoma 11Primary Myelofibrosis 10Myeloproliferative Disorders 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, T-Cell, Cutaneous 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myeloid, Accelerated Phase 9Neoplasms, Plasma Cell 8Dendritic Cell Sarcoma, Interdigitating 8Blast Crisis 8Recurrence 7Sezary Syndrome 6Myelodysplastic-Myeloproliferative Diseases 6Mycosis Fungoides 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6

Interventions

Therapeutics 2Specimen Handling 2Early Intervention, Educational 2pegfilgrastim 1cediranib 1X-Rays 1Palliative Care 1Neoadjuvant Therapy 1Methods 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Indocyanine Green 1Hypnosis 1High-Energy Shock Waves 1Filgrastim 1Exercise Test 1Educational Status 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Clostridium perfringens epsilon-toxin 1Analgesia 1Accelerometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Inflammatory Breast Neoplasms × Cyclophosphamide × Clear all
NCT00310089 2013-06-20

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡